Sign in

CIK 0001176309

  • Non-accelerated filer
  • Smaller reporting company

ORAMED PHARMACEUTICALS INC.

Sign in to watch
Ticker
ORMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980376008
Phone
+1 646-844-1164
Business address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Former names
Integrated Security Technologies, Inc., IGUANA VENTURES LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$225,530
in 2 filings, $226K under 10b5-1 plans

Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-01-03 Rabinowitz Michael Chief Commercial Officer Sale −1,425 $13.01 $19K 138,043
2023-01-03 Rabinowitz Michael Chief Commercial Officer Sale −11,900 $12.49 $149K 126,143
2022-07-28 Rabinowitz Michael Chief Commercial Officer Grant or award +30,000 139,468
2022-01-03 Rabinowitz Michael Chief Commercial Officer Grant or award +19,000 109,468
2022-01-03 Rabinowitz Michael Chief Commercial Officer Grant or award · Stock Option (right to buy) +32,000 32,000
2021-12-28 Rabinowitz Michael Chief Commercial Officer Shares withheld for taxes −9,532 $12.98 $124K 90,468
2021-08-04 Rabinowitz Michael Chief Commercial Officer Grant or award +100,000 100,000
2021-08-04 Rabinowitz Michael Chief Commercial Officer Grant or award · Stock Option (right to buy) +100,000 100,000

Page 1 of 1 · 8 trades